Home / Journals American Journal of Health Research / Mycobacterial Drug Resistance
Mycobacterial Drug Resistance
Submission Deadline: Apr. 30, 2016
Lead Guest Editor
Anand Kumar Maurya
Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
Guest Editors
  • Vijaya Lakshmi Nag
    Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
  • Surya Kant
    Department of Pulmonary Medicine, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Ram Awadh Singh Kushwaha
    Department of Pulmonary Medicine, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Amresh Kumar Singh
    Department of Microbiology, BRD Medical College, Gorakhpur, Uttar Pradesh, India
  • S.M. Wasiur Rahman
    Qatif Central Hospital, Ministory of Health, Dammam, Saudi Arabia
  • Santosh Kumar
    Department of Biosciences, University of Texas, Texas, USA
  • Vikram Saini
    Department of Microbiology, University of Alabama at Birmingham, Birmingham, USA
  • Mikiyas Amare Getu
    Department of Nursing, Woldia University, Woldia, Ethiopia
  • Kranthi Kunkalla
    Department of Hematopathology, University of Miami, Miami, FL - Florida, USA
  • Ameer Khusro
    Department of Plant Biology and Biotechnology, Loyola College, University of Madras, Chennai, Tamil Nadu, India
  • Fahriye Keskin
    Department of Microbiology, Dentistry Faculty, Istanbul University, İstanbul, Turkey
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=656). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.
Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide, and resistance to commonly used antituberculous drugs is increasing. DR-TB is a major threat to global public health as it is difficult to treat and often results in relapse or treatment failure. It is also a risk factor for the emergence of Multidrug-resistant tuberculosis (MDR-TB) that does not respond to at least isoniazid and rifampicin and Extensively drug-resistant TB (XDR-TB) defined as infection with MDR-TB strains additionally resistant either to a new-generation fluoroquinolone and an injectable agent or to three of the six main classes of second-line drugs.

The diagnosis of MDR and XDR TB is based on mycobacterial culture and drug susceptibility testing on liquid or solid media, with results available in weeks to months. To address such delay in TB diagnosis as well as to discretely improve the diagnosis accuracy, early detection of DR-TB allows starting of a proper treatment, which has an impact in the better control of the disease. Rapid molecular methods are available for detecting drug-resistant TB, shorter turnaround time, no need for growth of the organism, possibility for direct application in clinical samples, less biohazard risks, and feasibility for automation.

The aim of special issue is to collect excellence of latest research contributions in the field of Mycobacterial Drug Resistance. We are interested in Original research, Review, Short communications, Short reports, Technical notes, case reports and others are solicited in the following areas:

1. Epidemiology of DR-TB
2. Biologic and Molecular mechanism of DR-TB
3. Diagnosis of DR-TB: Conventional and Genotypic Methods
4. Potential Causes and Predictors for The Development of DR-TB
5. Newer Diagnostics for Technologies and Tools for DR-TB
6. Treatment and management of DR-TB
7. Prevention of nosocomial transmission of DR-TB
8. Newer anti-TB drugs for DR-TB
9. TB and HIV Co-Infection
10. Tuberculosis Infection and Reinfection
11. Immunology in Tuberculosis
12. Advances in Tuberculosis Research
13. Molecular epidemiology
14. Vaccine development
15. Antimicrobial Susceptibility Testing and Therapy of Infections with Nontuberculous Mycobacteria
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186